Collage photo Ryan Cassaday and Nitin Jain
Aug 18, 2024, 20:22
Chenyu Lin: Important CAR T-cell debate in ALL featuring Ryan Cassaday and Nitin Jain
Chenyu Lin, Assistant Professor of Medicine at Duke University School of Medicine, shared on X:
“Important CAR T-cell debate (Brexu-cel vs. Obe-cel in ALL) featuring Ryan Cassaday and Nitin Jain!
- Brexu-cel has long-term outcomes, reliable manufacturing, and ease of use.
- Obe-cel’s unique kinetics grant a favorable toxicity profile with seemingly comparable efficacy.
With shoutouts to the great work coming out of Lori Muffly ROCCA studies.”
Source: Chenyu Lin/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 11, 2025, 21:25
Jan 11, 2025, 21:11
Jan 11, 2025, 21:09
Jan 11, 2025, 17:09
Jan 11, 2025, 16:43
Jan 11, 2025, 16:33
Jan 11, 2025, 16:20
Jan 11, 2025, 16:15